The miR-29s/SETDB1/TP53 regulatory circuitry existing in NSCLC signifies that miR-29s directly downregulate SETDB1 while p53 inhibits the expression of SETDB1 by increasing the expression of miR-29s [14]. The gene discussed is TP53; the disease is non-small cell lung carcinoma.